Coya Therapeutics (COYA) to Release Earnings on Tuesday

Coya Therapeutics (NASDAQ:COYA) will likely be posting its quarterly earnings results before the market opens on Tuesday, March 18th. Analysts expect Coya Therapeutics to post earnings of ($0.32) per share for the quarter.

Coya Therapeutics Stock Performance

Shares of NASDAQ:COYA opened at $6.54 on Tuesday. Coya Therapeutics has a 1 year low of $4.75 and a 1 year high of $10.69. The stock has a market capitalization of $109.26 million, a P/E ratio of -10.06 and a beta of 0.31. The stock has a 50-day simple moving average of $6.22 and a 200-day simple moving average of $6.46.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on COYA. HC Wainwright restated a “buy” rating and issued a $18.00 price target on shares of Coya Therapeutics in a report on Monday, November 11th. Chardan Capital restated a “buy” rating and issued a $14.00 price target on shares of Coya Therapeutics in a report on Thursday, February 6th. Finally, D. Boral Capital restated a “buy” rating and issued a $15.00 price target on shares of Coya Therapeutics in a report on Monday.

Coya Therapeutics Company Profile

Coya Therapeutics, Inc, a clinical-stage biotechnology company, engages in the development of proprietary medicinal products to modulate the function of regulatory T cells (Tregs). The company's product candidate pipeline is based on therapeutic modalities, such as Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy.